Host Species Barriers to Influenza Virus Infections
Abstract
Most emerging infectious diseases in humans originate from animal reservoirs; to contain and eradicate these diseases we need to understand how and why some pathogens become capable of crossing host species barriers. Influenza virus illustrates the interaction of factors that limit the transmission and subsequent establishment of an infection in a novel host species. Influenza species barriers can be categorized into virus-host interactions occurring within individuals and host-host interactions, either within or between species, that affect transmission between individuals. Viral evolution can help surmount species barriers, principally by affecting virus-host interactions; however, evolving the capability for sustained transmission in a new host species represents a major adaptive challenge because the number of mutations required is often large.
Get full access to this article
View all available purchase options and get full access to this article.
References
1
T. Kuiken et al., Science309, 1680 (2005).
2
S. Olofsson, U. Kumlin, K. Dimock, N. Arnberg, Lancet Infect. Dis.5, 184 (2005).
3
J. Stevens et al., Science, in press; published online 20 March 2006.
4
S. J. Baigent, J. W. McCauley, Bioessays25, 657 (2003).
5
Y. Suzuki, Biol. Pharm. Bull.28, 399 (2005).
6
J. H. Beigel et al., N. Engl. J. Med.353, 1374 (2005).
7
R. A. Fouchier et al., Proc. Natl. Acad. Sci. U.S.A.101, 1356 (2004).
8
D. van Riel et al., Science, in press; published online 23 March 2006.
9
K. Shinya et al., Nature440, 435 (2006).
10
M. Hatta, P. Gao, P. Halfmann, Y. Kawaoka, Science293, 1840 (2001).
11
H. Chen et al., Nature436, 191 (2005).
12
J. Liu et al., Science309, 1206 (2005); published online 6 July 2005.
13
D. Kobasa et al., J. Virol.73, 6743 (1999).
14
S. H. Seo, E. Hoffmann, R. G. Webster, Nat. Med.8, 950 (2002).
15
H. Smith, C. Sweet, Rev. Infect. Dis.10, 56 (1988).
16
B. R. Murphy, R. G. Webster, in Fields Virology, B. N. Fields et al., Eds. (Lippincott-Raven, Philadelphia, 1996), vol. 1, ch. 46.
17
J. I. Slingenbergh, M. Gilbert, K. I. de Balogh, W. Wint, Rev. Sci. Tech.23, 467 (2004).
18
R. G. Webster, Lancet363, 234 (2004).
19
J. Keawcharoen et al., Emerg. Infect. Dis.10, 2189 (2004).
20
G. F. Rimmelzwaan et al., Am. J. Pathol.168, 176 (2006).
21
P. C. Crawford et al., Science310, 482 (2005); published online 26 September 2005.
22
R. M. Anderson, R. M. May, Infectious Diseases of Humans: Dynamics and Control (Oxford Univ. Press, Oxford, 1991).
23
M. E. J. Woolhouse, D. T. Haydon, R. Antia, Trends Ecol. Evol.20, 238 (2005).
24
N. M. Ferguson et al., Nature425, 681 (2003).
25
C. Viboud, R. F. Grais, B. A. Lafont, M. A. Miller, L. Simonsen, J. Infect. Dis.192, 233 (2005).
26
Y. Xia, J. R. Gog, B. T. Grenfell, Appl. Statist.54, 659 (2005).
27
A. J. McMichael, F. M. Gotch, G. R. Noble, P. A. Beare, N. Engl. J. Med.309, 13 (1983).
28
B. T. Grenfell et al., Science303, 327 (2004).
29
N. M. Ferguson, A. P. Galvani, R. M. Bush, Nature422, 428 (2003).
30
A. Fenton and A. B. Pedersen, Emerg. Infect. Dis.11, 1815 (2005).
31
M. Lipsitch et al., Science300, 1966 (2003); published online 23 May 2003.
32
J. O. Lloyd-Smith, S. J. Schreiber, P. E. Kopp, W. M. Getz, Nature438, 355 (2005).
33
J. K. Taubenberger et al., Nature437, 889 (2005).
34
E. Domingo, J. J. Holland, Annu. Rev. Microbiol.51, 151 (1997).
35
R. Sanjuan, A. Moya, S. F. Elena, Proc. Natl. Acad. Sci. U.S.A.101, 8396 (2004).
36
C. H. Woelk, E. C. Holmes, Mol. Biol. Evol.19, 2333 (2002).
37
R. Sanjuan, A. Moya, S. F. Elena, Proc. Natl. Acad. Sci. U.S.A.101, 15376 (2004).
38
R. Antia, R. R. Regoes, J. C. Koella, C. T. Bergstrom, Nature426, 658 (2003).
(0)eLetters
eLetters is a forum for ongoing peer review. eLetters are not edited, proofread, or indexed, but they are screened. eLetters should provide substantive and scholarly commentary on the article. Embedded figures cannot be submitted, and we discourage the use of figures within eLetters in general. If a figure is essential, please include a link to the figure within the text of the eLetter. Please read our Terms of Service before submitting an eLetter.
Log In to Submit a ResponseNo eLetters have been published for this article yet.
Information & Authors
Information
Published In
Science
Volume 312 | Issue 5772
21 April 2006
21 April 2006
Copyright
American Association for the Advancement of Science.
Submission history
Published in print: 21 April 2006
Authors
Metrics & Citations
Metrics
Article Usage
Altmetrics
Citations
Cite as
- Thijs Kuiken et al.
Export citation
Select the format you want to export the citation of this publication.
Cited by
- Avian influenza (H5N1) virus, epidemiology and its effects on backyard poultry in Indonesia: a review, F1000Research, 11, (1321), (2023).https://doi.org/10.12688/f1000research.125878.2
- Cross-species infection potential of avian influenza H13 viruses isolated from wild aquatic birds to poultry and mammals, Emerging Microbes & Infections, 12, 1, (2023).https://doi.org/10.1080/22221751.2023.2184177
- Pathogenicity and anti-infection immunity of animal H3N2 and H6N6 subtype influenza virus cross-species infection with tree shrews, Virus Research, 324, (199027), (2023).https://doi.org/10.1016/j.virusres.2022.199027
- Quantification of in vitro replication kinetics of Alagoas vesiculovirus isolates by digital droplet RT-PCR, Brazilian Journal of Microbiology, 54, 1, (491-497), (2023).https://doi.org/10.1007/s42770-023-00902-w
- RNA Sequencing Demonstrates That Circular RNA Regulates Avian Influenza Virus Replication in Human Cells, International Journal of Molecular Sciences, 23, 17, (9901), (2022).https://doi.org/10.3390/ijms23179901
- Investigation on Natural Infection of Covert Mortality Nodavirus in Farmed Giant Freshwater Prawn (Macrobrachium rosenbergii), Animals, 12, 11, (1370), (2022).https://doi.org/10.3390/ani12111370
- Time-resolved characterization of the innate immune response in the respiratory epithelium of human, porcine, and bovine during influenza virus infection, Frontiers in Immunology, 13, (2022).https://doi.org/10.3389/fimmu.2022.970325
- Multi-target Approaches of Epigallocatechin-3-O-gallate (EGCG) and its Derivatives against Influenza Viruses, Current Topics in Medicinal Chemistry, 22, 18, (1485-1500), (2022).https://doi.org/10.2174/1568026622666220127112056
- Avian influenza (H5N1) virus, epidemiology and its effects on backyard poultry in Indonesia: a review, F1000Research, 11, (1321), (2022).https://doi.org/10.12688/f1000research.125878.1
- Genetic and biological properties of H10N3 avian influenza viruses: A potential pandemic candidate?, Transboundary and Emerging Diseases, 69, 5, (2022).https://doi.org/10.1111/tbed.14458
- See more
Loading...
View Options
Check Access
Log in to view the full text
AAAS login provides access to Science for AAAS Members, and access to other journals in the Science family to users who have purchased individual subscriptions.
- Become a AAAS Member
- Activate your AAAS ID
- Purchase Access to Other Journals in the Science Family
- Account Help
Log in via OpenAthens.
Log in via Shibboleth.
More options
Purchase digital access to this article
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.